Kairos Pharma Ltd (KAPA)

Not featured in screeners

Not featured in screeners

Ticker: KAPA Exchange: ASE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Kairos Pharma Ltd

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

1.4

Murali Ramachandran VP of Research and Development Officer

Transaction date 25 Nov 2024

Purchase

Price

192.17

Quantity 90,082 +28.2%

Value US$1,869,458

2.9

Samuelson Doug Chief Financial Officer Officer

Transaction date 22 Nov 2024

Purchase

Price

493.31

Quantity 61,572 -17.3%

Value US$2,422,875

1.5

Yu John S CEO and Chairman Executive Director Large shareholder

Transaction date 20 Nov 2024

Purchase

Price

378.83

Quantity 26,221 +6.2%

Value US$2,670,473

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-11-25	2024-11-25	B Purchase	1.4 Murali Ramachandran VP of Research and Development Officer	90,082 +28.2% 192.17 US$1,869,458	90,082 +28.2%	192.17	US$1,869,458
2024-11-25	2024-11-22	B Purchase	2.9 Samuelson Doug Chief Financial Officer Officer	61,572 -17.3% 493.31 US$2,422,875	61,572 -17.3%	493.31	US$2,422,875
2024-11-21	2024-11-20	B Purchase	1.5 Yu John S CEO and Chairman Executive Director Large shareholder	26,221 +6.2% 378.83 US$2,670,473	26,221 +6.2%	378.83	US$2,670,473